Jason Reed
Internal Medicine · Minneapolis, MNNPI 1861502122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $299, 2.0 times the $146 reported in 2019. Among internal medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$180
- Novartis$142
- Novo Nordisk$111
- Lilly USA, LLC$105
- Nestle Healthcare Nutrition Inc.$95
- Corium, LLC$76
- plus $681 from 22 others
What the payments were for
- Food & beverage$1,390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $180 |
| Novartis | 9 | $142 |
| Novo Nordisk | 8 | $111 |
| Lilly USA, LLC | 7 | $105 |
| Nestle Healthcare Nutrition Inc. | 7 | $95 |
| Corium, LLC | 5 | $76 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $66 |
| Philips North America LLC | 4 | $60 |
| Pfizer | 4 | $59 |
| QOL Medical, LLC | 3 | $45 |
| Phadia US Inc. | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Exact Sciences | 2 | $32 |
| AstraZeneca | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Itamar Medical Inc | 1 | $25 |
| Echosens North America, Inc. | 1 | $25 |
| Lifescan, Inc. | 1 | $21 |
| MDD US Operations, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Biomerieux Inc | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$1,390 in reported general payments places this provider in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 110 | $141,710 |
| XareltoRivaroxaban | 65 | $84,664 |
| OzempicSemaglutide | 42 | $54,849 |
| MounjaroTirzepatide | 34 | $47,518 |
| MyrbetriqMirabegron | 33 | $35,950 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $21,751 |
| RybelsusSemaglutide | 12 | $20,517 |
| Serevent DiskusSalmeterol Xinafoate | 15 | $9,512 |
| PaxlovidNirmatrelvir/Ritonavir | 25 | $4,302 |
| Atorvastatin Calcium | 297 | $4,165 |
| BrilintaTicagrelor | 18 | $4,096 |
| Levothyroxine Sodium | 202 | $4,064 |
| Rosuvastatin Calcium | 233 | $3,325 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,056 |
| Losartan Potassium | 145 | $1,752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $59 | $146,013135 claims |
| Novo NordiskOzempic, Rybelsus | $111 | $75,36654 claims |
| Lilly USA, LLCMounjaro | $105 | $47,51834 claims |
| Astellas Pharma US IncMyrbetriq | $19 | $35,95033 claims |
| AstraZenecaBrilinta | $31 | $4,09618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Other internal medicine in Minneapolis
- Roy ChoMinneapolis$122K
- Mustafa ArainMinneapolis$44K
- Noah WillifordMinneapolis$42K
- Kathryn AndersonMinneapolis$34K
- Nadeem KhanMinneapolis$23K
- Oluwaremilekun Tolu AkinnawoMinneapolis$21K
- Beth ThielenMinneapolis$14K
- Amir MoheetMinneapolis$12K
- Timothy SchackerMinneapolis$11K
- Bassem RouphaelMinneapolis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.